A Study of Effect of Megakaryocytes and Platelets in Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
Testing Conversation Aid in Practice
- Status
- COMPLETED
- Phase
- N/A
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Relative Dose Intensity of Adjuvant Chemotherapy in Older Women With ER+ HER2- Breast Cancer.
- Status
- UNKNOWN
- Phase
- N/A
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Electronic Medical Record-Based Nudge to Reduce SLNB
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
- Status
- RECRUITING
- Phase
- NA
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)
- Status
- COMPLETED
- Phase
- NA
Examination of the Effect of Counselling and Follow-up After Breast Cancer Awareness Education
- Status
- COMPLETED
- Phase
- NA
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Improvements in Patient-reported Quality of Life
- Status
- RECRUITING
- Phase
- NA
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Experimental Study With Pretest/Posttest Groups Which the Intervention Group Have the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day
- Status
- UNKNOWN
- Phase
- NA